TG THERAPEUTICS, INC. Clearing Fees Revenue (Deprecated 2018-01-31)
TG THERAPEUTICS, INC. (TGTX) reported Clearing Fees Revenue (Deprecated 2018-01-31) of $38.09 thousand for the 3-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Income Statement › Other Income
us-gaap:ClearingFeesRevenue · last filed 2018-03-15
- TG THERAPEUTICS, INC. clearing fees revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $38.09K, a 0.00% change year-over-year.
- TG THERAPEUTICS, INC. clearing fees revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $38.10K, a 0.00% change year-over-year.
- TG THERAPEUTICS, INC. clearing fees revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $38.09K, a 0.00% change year-over-year.
- TG THERAPEUTICS, INC. clearing fees revenue (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $38.09K, a 0.00% change year-over-year.
| Period end | Clearing Fees Revenue (Deprecated 2018-01-31) 3 month | Clearing Fees Revenue (Deprecated 2018-01-31) 6 month | Clearing Fees Revenue (Deprecated 2018-01-31) 9 month | Clearing Fees Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $38.09K 10-K · filed 2018-03-15 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.29K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-09-30 | $38.10K 10-K · filed 2018-03-15 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.29K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-06-30 | $38.09K 10-K · filed 2018-03-15 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.28K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-03-31 | $38.09K 10-K · filed 2018-03-15 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.29K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-12-31 | $38.09K 10-K · filed 2018-03-15 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.29K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-09-30 | $38.10K 10-K · filed 2018-03-15 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.29K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $38.09K 10-K · filed 2018-03-15 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.28K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $38.09K 10-K · filed 2018-03-15 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.29K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $38.09K 10-K · filed 2017-03-16 | $76.19K derived: sum of 2 quarters · filed 2017-03-16 | $114.29K derived: sum of 3 quarters · filed 2017-03-16 | $152.38K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-09-30 | $38.10K 10-K · filed 2017-03-16 | $76.19K derived: sum of 2 quarters · filed 2017-03-16 | $114.29K derived: sum of 3 quarters · filed 2017-03-16 | $152.38K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $38.09K 10-K · filed 2017-03-16 | $76.19K derived: sum of 2 quarters · filed 2017-03-16 | $114.28K derived: sum of 3 quarters · filed 2017-03-16 | $152.38K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $38.09K 10-K · filed 2017-03-16 | $76.19K derived: sum of 2 quarters · filed 2017-03-16 | $114.29K derived: sum of 3 quarters · filed 2017-03-16 | $152.38K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $38.09K 10-K · filed 2016-03-15 | $76.19K derived: sum of 2 quarters · filed 2016-03-15 | $114.29K derived: sum of 3 quarters · filed 2016-03-15 | $152.38K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-09-30 | $38.10K 10-K · filed 2016-03-15 | $76.19K derived: sum of 2 quarters · filed 2016-03-15 | $114.29K derived: sum of 3 quarters · filed 2016-03-15 | |
| 2014-06-30 | $38.09K 10-K · filed 2016-03-15 | $76.19K derived: sum of 2 quarters · filed 2016-03-15 | ||
| 2014-03-31 | $38.09K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |